Logo - International Journal of Pharmaceutical Compounding

Compounding for Juvenile Idiopathic Arthritis and Other Pediatric Rheumatic Diseases

Author(s):  Harrington Amy, Williams LaVonn

Issue:  Jul/Aug 2022 - Volume 26, Number 4
View All Articles in Issue

Abstract:  Medications on the market for the treatment of arthritis are more commonly appropriate for adult arthritic patients. However, for patients with juvenile arthritis, a compounding pharmacist can prepare specialized medications for those patients who are in need of a specific dosage, or for those patients who require a different dosage form. Additionally, more than one active ingredient can be combined in pharmacy compounding to meet a specific patient’s needs. Compounded topical/transdermal preparations can provide customized medication options, which may not be commercially available, for pediatric patients with juvenile arthritis.

Related Keywords: Amy Harrington, LaVonn Williams, juvenile arthritis, topical preparations, transdermal administration, pediatric rheumatic disease, autoimmune disorders, autoinflammatory diseases, inflammation, anti-inflammatory agents, nonsteroidal anti-inflammatory drugs, NSAIDs, corticosteroids, disease-modifying antirheumatic drugs, DMARDs, biologic DMARDS, tumor necrosis factor inhibitors, medication adherence

Related Categories: PAIN MANAGEMENT, PEDIATRICS, ALLERGY/IMMUNOLOGY/INFLAMMATION, MUSCULOSKELETAL DISORDERS

Purchase this article for download in electronic PDF format from IJPC at for $35 at:
http://www.ijpc.com/Products/ProductAddToCart.cfm?PID=5086

Search the entire IJPC archive by keyword, topic, or issue at:
http://ijpc.com/Products